Showing results (101-110 of 210) with videos related to

Sort By:
Pageof 21
Neuroscience and Biobehavioral Reviews|September 19, 2016
Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networksMason M Silveira, Jonathon C Arnold, Steven R Laviolette, et al.
Harm Reduction Journal|May 28, 2024
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22)Llewellyn Mills, Jonathon C Arnold, Anastasia Suraev, et al.
European Journal of Pharmacology|March 20, 2022
In vitro evaluation of the interaction of the cannabis constituents cannabichromene and cannabichromenic acid with ABCG2 and ABCB1 transportersMaia G Etchart, Lyndsey L Anderson, Adam Ametovski, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Effects of Chronic 100 mg/kg Cannabidiol Treatment in Male Double Transgenic <i>APP<sub>Swe</sub>/PS1∆E9</i> MiceGeorgia Watt, Juan Olaya, Gerald Muench, et al.
Behavioural Brain Research|September 28, 2011
Cognition in female transmembrane domain neuregulin 1 mutant miceRose Chesworth, Laura Downey, Warren Logge, et al.
Frontiers in Psychiatry|February 23, 2018
The Endocannabinoid System across Postnatal Development in Transmembrane Domain <i>Neuregulin 1</i> Mutant MiceRose Chesworth, Leonora E Long, Cynthia Shannon Weickert, et al.
Behavioural Brain Research|September 10, 2019
Behavioural effects of high fat diet in adult Nrg1 type III transgenic miceJerzy Zieba, Margaret J Morris, Cynthia Shannon Weickert, et al.
Behavioural Brain Research|May 16, 2006
Behavioural effects of chronic haloperidol and risperidone treatment in ratsTim Karl, Liesl Duffy, Elizabeth O'brien, et al.
Psychopharmacology|May 1, 2026
Genetic risk for schizophrenia modulates WIN 55,212-2 reward: Evidence from a heterozygous transmembrane domain neuregulin 1 mutant mouse modelRose Chesworth, Georgia Watt, Jaime Howard, et al.
Behavioural Brain Research|June 25, 2019
First behavioural assessment of a novel Immp2l knockdown mouse model with relevance for Gilles de la Tourette syndrome and Autism spectrum disorderFabian Kreilaus, Rose Chesworth, Valsamma Eapen, et al.
Pageof 21